Zydus Cadila Gets US FDA Approval for Glycopyrrolate Injection
The pharmaceutical company ‘Zydus Cadila’ has recently announced that, it has received the final approval from the US FDA for the purpose of marketing the Glycopyrrolate Injection in the Single-Dose Vials of Strengths 0.2 mg/mL and 0.4 mg/2 mL and 1 mg/5 mL and 4 mg/20 mL Multiple-Dose Vials. The Glycopyrrolate injection has been mainly […]
Continue Reading